Clinical Trial Update: A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose [Phase 1]

View source ↗

Summary

A Phase 1 trial update reports the completion of a study evaluating CT-868 and its relationship with insulin secretory response and ambient blood glucose in dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• CT-868

Snippet

Sponsor: Carmot Therapeutics, Inc. | Conditions: Diabetes | Phase 1 | Status: COMPLETED